CClinicalTrials.gg
Not yet recruitingNCT07064824ACPSUpdated Jul 30, 2025

Adaptive Cell Phone Support (ACPS)

An interventional study of Adaptive Cell Phone Support and Computer-Delivered Cell Phone Support in Medication Adherence, sponsored by Children's Hospital Los Angeles. Not yet recruiting at 1 site in United States. Open to participants aged 15 Years to 20 Years. Per ClinicalTrials.gov, last updated 2025-07-30.

Sponsored by Children's Hospital Los Angeles · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
96
Allocation
Randomized
Ages
15 Years to 20 Years
Sex
All
01

Study summary

The goal of this pilot clinical trial is to test a mobile health intervention for promoting medication adherence in a population of adolescents and young adults with chronic health conditions. The main question it aims to answer is:

-Is an adaptive intervention (personalizing the intensity of support based on patients' needs) efficacious for promoting medication adherence Researchers will compare the adaptive intervention to automated text message reminders see if the adaptive intervention shows stronger positive effects on medication adherence.

Read the detailed description

Plan to enroll 96 participants in this study, which is a sequential randomized trial.

02

Conditions studied

  • Medication Adherence

Keywords

  • Adolescents
  • Mobile health
  • chronic illness
03

In context

Medication Adherence

221 studies on the registry are indexed under Medication Adherence; 108 are open to participants now.

This study's planned enrollment of 96 is below the median of 118 across 188 interventional studies indexed under Medication Adherence.

Browse Medication Adherence studies →

Lead sponsor

Children's Hospital Los Angeles is the lead sponsor of 150 studies on the registry; 46 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 6 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 20 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Children's Hospital Los Angeles patient
  • between 15-20 years old
  • taking at least one oral medication per day for a chronic health condition
  • English speaking
  • demonstrating sufficient cognitive capacity to engage in the assent/consent process and study procedures

There is no exclusion criteria.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
96 participants (estimated)

Study arms

  • Experimental
    Adaptive Cell Phone Support

    Computer-delivered cell phone support (reminders, problem-solving, referrals to resources) and responsive human coaching (phone calls, test messages, in-app messaging) to improve medication adherence.

    Behavioral: Adaptive Cell Phone Support · Behavioral: Computer-Delivered Cell Phone Support

  • Experimental
    Computer-Delivered Cell Phone Support

    Computer-delivered cell phone support (reminders, problem-solving, referrals to resources)

    Behavioral: Computer-Delivered Cell Phone Support

  • Active comparator
    Automated Text Reminders

    Scheduled one-way text automated message reminders to take medication

    Behavioral: Automated Text Reminders

Interventions

  • BehavioralAdaptive Cell Phone Support

    Mobile health adherence promotion based on the supportive accountability model

  • BehavioralComputer-Delivered Cell Phone Support

    Mobile health adherence promotion based on the supportive accountability model

  • BehavioralAutomated Text Reminders

    Scheduled text reminder to take medication

06

What researchers measure

Primary outcomes

  1. Mean scores on the Mobile Health App Usability Questionnaire

    Higher scores indicate greater ease with which users can use technology to achieve a particular goal; the minimum value of this questionnaire is 1 and the maximum value is 7.

    Time frame: Baseline to 12 weeks

  2. Total scores on the theoretical framework of acceptability questionnaire

    Higher scores indicate a greater "extent to which people delivering or receiving a healthcare intervention consider it to be appropriate, based on anticipated or experienced cognitive and emotional responses to the intervention"; the minimum value of this questionnaire is 7 and the maximum value is 35.

    Time frame: Baseline to 12 weeks

  3. Total scores on the Visual Analogue Scale

    Percentage of doses taken our of 100%; higher numbers indicate greater medication adherence. This scale presents participants with a line, marked 0 on the left and 100 on the right, and participants can drag a marker to the place on the line that best visually indicated their adherence.

    Time frame: Baseline to 12 weeks

  4. Total scores on Rollnick's Readiness Ruler

    Higher scores on this measure indicate more motivation to take medication as prescribed; the minimum value of this questionnaire is 0 and the maximum value is 10.

    Time frame: Baseline to 12 weeks

  5. Total Transition Readiness scores on the Successful Transition to Adulthood with Therapeutic = Rx Questionnaire

    Higher scores on extent to which patients are prepared to manage their health condition as adults, outside of the pediatric system; ; the minimum value of this questionnaire is 0 and the maximum value is 90.

    Time frame: Baseline to 12 weeks

07

Study locations

1 site
  • Children Hospital Los Angeles
    Los Angeles, California 90027, United States
    • Caitlin Sayegh, PhD · Contact · cssayegh@chla.usc.edu · 13233617748
    • Caitlin Sayegh, PhD · Principal investigator
08

References and documents

Individual participant data

Plan to share: Yes — The data will include electronically-administered survey items assessing demographic characteristics, intervention usability, intervention acceptability, medication adherence, motivation for adherence, transition readiness skills, and allocation of treatment responsibility as well as medication regimen complexity data and pharmacy possession refill rates abstracted from the electronic medical chart, and behavioral engagement data collected via the Computerized Intervention Authoring Software.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07064824
Lead sponsor
Children's Hospital Los Angeles
Responsible party
Caitlin Sayegh (Assistant Professor of Clinical Pediatrics, Children's Hospital Los Angeles) — Principal investigator
First posted
Jul 15, 2025
Start date
Aug 1, 2027 (estimated)
Primary completion
Jul 30, 2029 (estimated)
Completion
Jul 30, 2030 (estimated)
Last update
Jul 30, 2025

Study contacts

Caitlin Sayegh, PhD
Contact
cssayegh@chla.usc.edu
13233617748
Caitlin Sayegh, PhD
principal investigator · Children's Hospital Los Angeles

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion